Betrixaban
Get a Quick Quote Now
Select Packaging
Product Description
Product
Betrixaban
CAS
330942-05-7
Formula
C23H22ClN5O3
Synonym
Betrixaban, 330942-05-7, PRT054021, N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, Bevyxxa, PRT 054021, PRT-054021, Betrixaban [USAN], N-(5-Chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide, 74RWP7W0J9, CHEMBL512351, 330942-05-7 (free base), Betrixaban (USAN), N-(5-Chloropyridin-2-yl)-2-((4-(N,N-dimethylcarbamimidoyl)benzoyl)amino)-5- methoxybenzamide, N-(5-chloropyridin-2-yl)-2-[4-(N,N-dimethylcarbamimidoyl)benzamido]-5-methoxybenzamide, Benzamide, N-(5-chloro-2-pyridinyl)-2-((4-((dimethylamino)iminomethyl)benzoyl)amino)-5-methoxy-, Betrixaban [USAN:INN], UNII-74RWP7W0J9, Bevyxxa (TN), BETRIXABAN [MI], BETRIXABAN [INN], BETRIXABAN [WHO-DD], SCHEMBL158591, GTPL9602, BETRIXABAN [ORANGE BOOK], DTXSID10954727, EX-A358, CHEBI:140421, AMY11262, BCP01903, BDBM50249298, MFCD16038040, s5388, AKOS005146070, BCP9000395, CCG-269250, DB12364, SB16951, compound 11 [PMID: 19297154], NCGC00371122-02, NCGC00371122-04, AC-30214, AS-56192, HY-10268, DB-068750, FT-0663094, D08873, EN300-18167087, Q4898219
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Notes
Betrixaban is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Betrixaban
Product Description
Product
Betrixaban
CAS
330942-05-7
Formula
C23H22ClN5O3
Synonym
Betrixaban, 330942-05-7, PRT054021, N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, Bevyxxa, PRT 054021, PRT-054021, Betrixaban [USAN], N-(5-Chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide, 74RWP7W0J9, CHEMBL512351, 330942-05-7 (free base), Betrixaban (USAN), N-(5-Chloropyridin-2-yl)-2-((4-(N,N-dimethylcarbamimidoyl)benzoyl)amino)-5- methoxybenzamide, N-(5-chloropyridin-2-yl)-2-[4-(N,N-dimethylcarbamimidoyl)benzamido]-5-methoxybenzamide, Benzamide, N-(5-chloro-2-pyridinyl)-2-((4-((dimethylamino)iminomethyl)benzoyl)amino)-5-methoxy-, Betrixaban [USAN:INN], UNII-74RWP7W0J9, Bevyxxa (TN), BETRIXABAN [MI], BETRIXABAN [INN], BETRIXABAN [WHO-DD], SCHEMBL158591, GTPL9602, BETRIXABAN [ORANGE BOOK], DTXSID10954727, EX-A358, CHEBI:140421, AMY11262, BCP01903, BDBM50249298, MFCD16038040, s5388, AKOS005146070, BCP9000395, CCG-269250, DB12364, SB16951, compound 11 [PMID: 19297154], NCGC00371122-02, NCGC00371122-04, AC-30214, AS-56192, HY-10268, DB-068750, FT-0663094, D08873, EN300-18167087, Q4898219
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Notes
Betrixaban is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
